76 related articles for article (PubMed ID: 19173283)
1. Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients.
Erfurt C; Müller E; Emmerling S; Klotz C; Hertl M; Schuler G; Schultz ES
Int J Cancer; 2009 May; 124(10):2341-6. PubMed ID: 19173283
[TBL] [Abstract][Full Text] [Related]
2. Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity.
Erfurt C; Sun Z; Haendle I; Schuler-Thurner B; Heirman C; Thielemans K; van der Bruggen P; Schuler G; Schultz ES
J Immunol; 2007 Jun; 178(12):7703-9. PubMed ID: 17548607
[TBL] [Abstract][Full Text] [Related]
3. Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen.
Bluemel C; Hausmann S; Fluhr P; Sriskandarajah M; Stallcup WB; Baeuerle PA; Kufer P
Cancer Immunol Immunother; 2010 Aug; 59(8):1197-209. PubMed ID: 20309546
[TBL] [Abstract][Full Text] [Related]
4. Identification of the human melanoma-associated chondroitin sulfate proteoglycan antigen epitope recognized by the antitumor monoclonal antibody 763.74 from a peptide phage library.
Geiser M; Schultz D; Le Cardinal A; Voshol H; García-Echeverría C
Cancer Res; 1999 Feb; 59(4):905-10. PubMed ID: 10029083
[TBL] [Abstract][Full Text] [Related]
5. Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms.
Yang J; Price MA; Neudauer CL; Wilson C; Ferrone S; Xia H; Iida J; Simpson MA; McCarthy JB
J Cell Biol; 2004 Jun; 165(6):881-91. PubMed ID: 15210734
[TBL] [Abstract][Full Text] [Related]
6. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.
Zarour HM; Storkus WJ; Brusic V; Williams E; Kirkwood JM
Cancer Res; 2000 Sep; 60(17):4946-52. PubMed ID: 10987311
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J
Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.
Pluschke G; Vanek M; Evans A; Dittmar T; Schmid P; Itin P; Filardo EJ; Reisfeld RA
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9710-5. PubMed ID: 8790396
[TBL] [Abstract][Full Text] [Related]
9. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E
Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.
Takahashi T; Chapman PB; Yang SY; Hara I; Vijayasaradhi S; Houghton AN
J Immunol; 1995 Jan; 154(2):772-9. PubMed ID: 7814883
[TBL] [Abstract][Full Text] [Related]
11. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules.
Chiari R; Hames G; Stroobant V; Texier C; Maillère B; Boon T; Coulie PG
Cancer Res; 2000 Sep; 60(17):4855-63. PubMed ID: 10987298
[TBL] [Abstract][Full Text] [Related]
12. In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.
Hasegawa K; Noguchi Y; Koizumi F; Uenaka A; Tanaka M; Shimono M; Nakamura H; Shiku H; Gnjatic S; Murphy R; Hiramatsu Y; Old LJ; Nakayama E
Clin Cancer Res; 2006 Mar; 12(6):1921-7. PubMed ID: 16551878
[TBL] [Abstract][Full Text] [Related]
13. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.
Zarour HM; Maillere B; Brusic V; Coval K; Williams E; Pouvelle-Moratille S; Castelli F; Land S; Bennouna J; Logan T; Kirkwood JM
Cancer Res; 2002 Jan; 62(1):213-8. PubMed ID: 11782380
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase.
Kobayashi H; Kokubo T; Sato K; Kimura S; Asano K; Takahashi H; Iizuka H; Miyokawa N; Katagiri M
Cancer Res; 1998 Jan; 58(2):296-301. PubMed ID: 9443408
[TBL] [Abstract][Full Text] [Related]
15. Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells.
Torisu-Itakura H; Schoellhammer HF; Sim MS; Irie RF; Hausmann S; Raum T; Baeuerle PA; Morton DL
J Immunother; 2011 Oct; 34(8):597-605. PubMed ID: 21904216
[TBL] [Abstract][Full Text] [Related]
16. Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts.
Jandus C; Bioley G; Dojcinovic D; Derré L; Baitsch L; Wieckowski S; Rufer N; Kwok WW; Tiercy JM; Luescher IF; Speiser DE; Romero P
Cancer Res; 2009 Oct; 69(20):8085-93. PubMed ID: 19808957
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry assessment of residual melanoma cells in tumor-infiltrating lymphocyte cultures.
Richards JO; Treisman J; Garlie N; Hanson JP; Oaks MK
Cytometry A; 2012 May; 81(5):374-81. PubMed ID: 22467596
[TBL] [Abstract][Full Text] [Related]
18. Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.
Eisenmann KM; McCarthy JB; Simpson MA; Keely PJ; Guan JL; Tachibana K; Lim L; Manser E; Furcht LT; Iida J
Nat Cell Biol; 1999 Dec; 1(8):507-13. PubMed ID: 10587647
[TBL] [Abstract][Full Text] [Related]
19. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
Somasundaram R; Swoboda R; Caputo L; Lee A; Jackson N; Marincola FM; Guerry D; Herlyn D
Int J Cancer; 2003 Apr; 104(3):362-8. PubMed ID: 12569560
[TBL] [Abstract][Full Text] [Related]
20. Detection of spontaneous CD4+ T-cell responses in melanoma patients against a tyrosinase-related protein-2-derived epitope identified in HLA-DRB1*0301 transgenic mice.
Paschen A; Song M; Osen W; Nguyen XD; Mueller-Berghaus J; Fink D; Daniel N; Donzeau M; Nagel W; Kropshofer H; Schadendorf D
Clin Cancer Res; 2005 Jul; 11(14):5241-7. PubMed ID: 16033842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]